Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated RNA trans splicing

Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated RNA trans splicing

US Patent 8053232 · Granted Nov 8, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune di2025
Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune di2025
Method to identify subjects at higher risk to develop an autoimmune disease base2025
Electronic access control multi-factor authentication using centralized hardware2024
Soluble interleukin-7 receptor (sIL7R) modulating therapy to treat autoimmune di2023
Method of isolating circulating tumor cells2023
Soluble interleukin-7 receptor (sIL7R) modulating therapy to treat autoimmune di2021
Compositions and methods for correction of heritable ocular disease2021
Method to identify subjects at higher risk to develop an autoimmune disease base2021
Method of isolating circulating tumor cells2018
Synthetic regulation of gene expression2017
Methods and compositions for synthesis of nucleic acid molecules using multiple 2016